The AlloHSC-iNKT cell product demonstrated cytotoxicity against multiple tumor cell lines (50); the baseline level of tumor killing mediated by NKG2D and other activating NK receptors (52) could thus be further enhanced using CARs for high-fidelity recognition. Here, KLRK1 is linked to neoplasm.